Previous 10 | Next 10 |
PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘ Dupuytren’s disease: a localized and accessible human fibrotic dis...
Short Squeeze Stocks To Watch The first day of 2023’s stock market season begins today, and of course, there are plenty of cheap stocks to watch. Also known as penny stocks , these are the lowest-priced equities known for their explosiveness. According to the standard definition of...
Top 3 Strategies to Use for Trading Penny Stocks Next Year Penny stocks are a popular but risky investment option due to their potential for high returns. Having a trading strategy with penny stocks is important in order to minimize the risk involved and maximize profits. A good trading strat...
180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company, has released a letter to shareholders; the letter is signed by CEO James Woody. In the letter, Woody notes that the company’s priority continues to be its clinical programs, repurposing anti-tumor necrosis factor (&...
180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company, has closed on its previously announced registered direct offering. The offering, which was with a single healthcare-focused U.S. institutional investor, was comprised of 1,714,286 shares of the company’s common stoc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With a contentious time in 2022 coming to a close, it may be helpful to look back and consider the most sold-off stocks last year. Similar to learning from prior mistakes, investors may be able to garner lessons from the worst-...
PALO ALTO, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the “Company”), a clinical-stage biotechnology company, today announced the closing of its previously announced registered direct offering priced at-the-m...
180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company, has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor. The agreement is for a registered direct offering to include the purchase and sale of 1,714,286 shares of the company...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’re starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday Moving stocks this morning are offerings, bankruptc...
180 Life Sciences ( NASDAQ: ATNF ) shares surged on Tuesday after the biotechnology company announced a $6M registered direct offering priced at-the-market under Nasdaq rules. The firm entered into a definitive agreement with a single healthcare-focused U.S. institutional investor...
News, Short Squeeze, Breakout and More Instantly...
180 Life Sciences Corp Com Company Name:
ATNF Stock Symbol:
NASDAQ Market:
180 Life Sciences Corp Com Website:
180 Life Sciences (NASDAQ: ATNF) today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “hearings panel”) of the Nasdaq Stock Market LLC that it has granted the company’s request for additional time to achieve compliance with Nasdaq’...
PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq S...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...